Follow
Rachana Patel
Rachana Patel
CRUK Beatson Institute
Verified email at beatson.gla.ac.uk
Title
Cited by
Cited by
Year
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments
B Peck, ZT Schug, Q Zhang, B Dankworth, DT Jones, E Smethurst, ...
Cancer & metabolism 4, 1-18, 2016
2182016
2, 4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer
A Blomme, CA Ford, E Mui, R Patel, C Ntala, LE Jamieson, M Planque, ...
Nature Communications 11 (1), 2508, 2020
1242020
Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer
I Ahmad, E Mui, L Galbraith, R Patel, EH Tan, M Salji, AG Rust, ...
Proceedings of the National Academy of Sciences 113 (29), 8290-8295, 2016
1172016
Plakophilin3 downregulation leads to a decrease in cell adhesion and promotes metastasis
ST Kundu, P Gosavi, N Khapare, R Patel, AS Hosing, GB Maru, A Ingle, ...
International journal of cancer 123 (10), 2303-2314, 2008
1042008
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
R Patel, M Gao, I Ahmad, J Fleming, LB Singh, TS Rai, AB McKie, ...
The Journal of clinical investigation 123 (3), 1157-1175, 2013
992013
Ras mutation cooperates with β-catenin activation to drive bladder tumourigenesis
I Ahmad, R Patel, Y Liu, LB Singh, MM Taketo, XR Wu, HY Leung, ...
Cell death & disease 2 (3), e124-e124, 2011
952011
Polymeric black tea polyphenols induce phase II enzymes via Nrf2 in mouse liver and lungs
R Patel, G Maru
Free Radical Biology and Medicine 44 (11), 1897-1911, 2008
912008
Polymeric black tea polyphenols inhibit 1, 2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/β-catenin pathway
R Patel, A Ingle, GB Maru
Toxicology and applied pharmacology 227 (1), 136-146, 2008
722008
HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer
I Ahmad, R Patel, LB Singh, C Nixon, M Seywright, RJ Barnetson, ...
Proceedings of the National Academy of Sciences 108 (39), 16392-16397, 2011
682011
Targeting the EGFR-family for therapy: biological challenges and clinical perspective
R Patel, H Y Leung
Current pharmaceutical design 18 (19), 2672-2679, 2012
672012
SPRY2 loss enhances ErbB trafficking and PI3K/AKT signalling to drive human and mouse prostate carcinogenesis
M Gao, R Patel, I Ahmad, J Fleming, J Edwards, S McCracken, ...
EMBO molecular medicine 4 (8), 776-790, 2012
572012
Dietary turmeric modulates DMBA-induced p21ras, MAP kinases and AP-1/NF-κB pathway to alter cellular responses during hamster buccal pouch carcinogenesis
R Garg, A Ingle, G Maru
Toxicology and applied pharmacology 232 (3), 428-439, 2008
532008
Chemopreventive herbal anti-oxidants: current status and future perspectives
R Patel, R Garg, S Erande, GB Maru
Journal of clinical biochemistry and nutrition 40 (2), 82-91, 2007
522007
Polymeric black tea polyphenols inhibit mouse skin chemical carcinogenesis by decreasing cell proliferation
R Patel, R Krishnan, A Ramchandani, G Maru
Cell Proliferation 41 (3), 532-553, 2008
502008
Repurposing screen identifies mebendazole as a clinical candidate to synergise with docetaxel for prostate cancer treatment
LK Rushworth, K Hewit, S Munnings-Tomes, S Somani, D James, ...
British journal of cancer 122 (4), 517-527, 2020
372020
Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation
K Mardilovich, M Gabrielsen, L McGarry, C Orange, R Patel, E Shanks, ...
Molecular cancer therapeutics 14 (1), 246-258, 2015
362015
Activation of β-catenin cooperates with loss of Pten to drive AR-independent castration-resistant prostate cancer
R Patel, EA Brzezinska, P Repiscak, I Ahmad, E Mui, M Gao, A Blomme, ...
Cancer Research 80 (3), 576-590, 2020
352020
Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis
CJ Loveridge, EJ Mui, R Patel, EH Tan, I Ahmad, M Welsh, J Galbraith, ...
Cancer research 77 (12), 3158-3168, 2017
282017
Sprouty2 loss‐induced IL 6 drives castration‐resistant prostate cancer through scavenger receptor B1
R Patel, J Fleming, E Mui, C Loveridge, P Repiscak, A Blomme, V Harle, ...
EMBO Molecular Medicine 10 (4), e8347, 2018
262018
Loss of N‐WASP drives early progression in an Apc model of intestinal tumourigenesis
HT Morris, L Fort, HJ Spence, R Patel, DF Vincent, JH Park, SB Snapper, ...
The Journal of Pathology 245 (3), 337-348, 2018
202018
The system can't perform the operation now. Try again later.
Articles 1–20